NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

This is very interesting. It appears that an enhanced antigen specific Th1 immune response could be used to treat autoimmune diseases that are specific to the Th1 pathway:

How does this affect autoimmune disease?
In some people with autoimmune disease, patterns showing a dominance to either the Th1 or Th2 pathway have been shown. Although there are exceptions, the following table shows the conditions that are most commonly associated with a Th1 or Th2 dominant state:

TH1 dominant conditions:

Type I diabetes
Multiple sclerosis
Hashimoto’s Thyroiditis
Grave’s Disease
Crohn’s Disease
Psoriasis
Sjoren’s Syndrome
Celiac Disease
Lichen Planus
Rheumatoid Arthritis
Chronic viral infections

https://hypothyroidmom.com/autoimmune-patients-have-you-heard-of-th1-and-th2-dominance/